Encompass Health EHC
Valuation
Multiples measured against the stock's own five-year history
Around its usual level · 47th percentile, 5-year average 20.6x
#1763 of 2996 stocks by PE (1 = cheapest)
Above its usual level · 71st percentile, 5-year average 4.4x
#4464 of 5338 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 90th percentile, 5-year average 1.6x
#2721 of 5161 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 4.89 | – | 4.44 | 71% (pricier than usual) | #4464 of 5338 (1 = cheapest) |
| PE | 20.88 | 19.40 | 20.56 | 47% (cheaper than usual) | #1763 of 2996 (1 = cheapest) |
| PS | 2.07 | 1.91 | 1.61 | 90% (pricier than usual) | #2721 of 5161 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on EHC.
Sign in to join the discussion.